A model capable of predicting the recurrence of gallbladder cancer within one year after surgery using only preoperative ...

Recently, new treatment methods for benign prostatic hyperplasia (BPH) have been introduced, attracting significant attention ...

Korea’s Lunit reported 37.077 billion won ($26.9 million) in consolidated revenue for the first half of 2025, up 113.5 ...

Korea has approved MSD’s Winrevair (sotatercept) for pulmonary arterial hypertension (PAH), marketed by Merck in the U.S. and ...

The Ministry of Food and Drug Safety (MFDS) has approved Gilead Sciences’ chimeric antigen receptor T-cell (CAR-T) therapy ...

During the hot summer months, staying hydrated is essential for good health. But can coffee, soda, or milk serve as effective ...

What does it mean to care -- deeply, instinctively, and culturally? In this series, "Caring the Korean Way," we explore the ...

Korea’s Daewoong Pharmaceutical and Daewoong Therapeutics said their semaglutide microneedle patch has achieved more than 80 ...

Ahead of the National Assembly debate on the “Tattoo Artist Act,” which would allow non-medical professionals to perform ...

Korean medical AI firm VUNO pulled in 9.3 billion won ($6.7 million) in second-quarter consolidated revenue, up 45 percent ...

Yonsei University Health System and the National Institute of Medical Device Safety Information will jointly host the “2025 ...

Etomidate, a general anesthetic agent that has been reported to be illegally administered as a substitute for propofol, has ...